Insider trade

Beta Bionics (BBNX): Chief Commercial Officer exercised options on 775 units

Mark Hopman, Chief Commercial Officer at Beta Bionics, reported an option exercise of 775 units.

775
Derivative units
Traded
Nov 16, 2026
Filed
Nov 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2026InsiderOfficer sold ~$7K of BBNX shares in the open market
  2. Oct 7, 20265% stakeT. Rowe Price Associates, Inc. reported a passive stake (13G) of 16.6%
  3. Oct 14, 2026InsiderOfficer sold ~$13K of BBNX shares in the open market
  4. Oct 21, 2026FDAFDA device clearance: Mint ACE Pump
  5. Oct 26, 2026InsiderOfficer sold ~$16K of BBNX shares in the open market
  6. Oct 27, 2026Company filing · Form 8-K · ResultsReported its results
  7. Oct 27, 2026InsiderOfficer sold ~$58K of BBNX shares in the open market
  8. Nov 2, 2026InsiderOfficer sold ~$6.3K of BBNX shares in the open market
  9. Nov 5, 2026InsiderCFO sold ~$6.5K of BBNX shares in the open market
  10. Nov 9, 20265% stakeLevy Guy reported a passive stake (13G) of 8.7%
  11. Nov 9, 2026InsiderCFO sold ~$13K of BBNX shares in the open market
  12. Nov 11, 2026InsiderCFO sold ~$153K of BBNX shares in the open market
  13. Nov 16, 20265% stakePoint72 Asset Management, L.P. reported a passive stake (13G) of 1.8%
  14. Nov 16, 20265% stakeDivisadero Street Capital Management, LP reported a passive stake (13G) of 0.1%
  15. Nov 16, 2026InsiderOfficer sold ~$13K of BBNX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Beta Bionics

For Beta Bionics, OQRO holds 13 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BBNX page.

Other recent filings by Mark Hopman, Chief Commercial Officer

The full history of Mark Hopman, Chief Commercial Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Beta Bionics (BBNX) insider traded, and how much?

Mark Hopman, Chief Commercial Officer at Beta Bionics, reported an option exercise of 775 units. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Nov 16, 2026. Filed: Nov 18, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Beta Bionics recently?

For Beta Bionics, OQRO holds 13 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the BBNX page.

Does this mean BBNX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Beta Bionics

Everything OQRO holds on this company is on its BBNX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data